One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy

Overview of attention for article published in Frontiers in Cardiovascular Medicine, August 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,753 followers.

RT @danseungkim: After 9+ months of review, we are pleased that this manuscript was accepted and is in press! https://t.co/zaL5lS3B6g @C…

After 9+ months of review, we are pleased that this manuscript was accepted and is in press! https://t.co/zaL5lS3B6g @ChadSWeldy @vnparikh @MWheelerMD @NurseSalisbury @euanashley @StanCVFellows

Observing a drug's journey from development to implementation has been a remarkable experience. #HCM #SCICD https://t.co/CYyowh5o9Q

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.